Neurim Pharmaceuticals markets its new drugs through strategic alliances with reputable marketing and distribution partners on whose marketing expertise we rely.

Neurim has so far established marketing and sales agreements with Teva, Takeda, Aspen Pharmacare, DKSH, Flynn, Medice, Italfarmaco, Biocodex, Kuhnil Pharm, Fidia, Juste and Biopas.
We are actively seeking additional strategic alliances.

Please feel free to contact us:

Dr. Hansjoerg Jakubetz
Director Corporate Business Development

  • Text size: A A A
  • Circadin
  • Recent news

    • Neurim Pharmaceuticals’ New Paediatric Prolonged-Release Melatonin (“PedPRM”) to Be Marketed by BIOCODEX Oy in Finland
    • Circadin is celebrating 10 years in market!
    • Positive Phase III Results for Neurim Pharmaceuticals’ Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder (ASD) Presented at the World Sleep Congress in Prague
  • Partners